As of 2025-09-19, the Relative Valuation of Mesa Laboratories Inc (MLAB) is 22.04 USD. This relative valuation is based on P/E multiples. With the latest stock price at 65.15 USD, the upside of Mesa Laboratories Inc based on Relative Valuation is -66.2%.
The range of the Relative Valuation is (2.12) - 51.47 USD.
| Range | Selected | |
| Trailing P/E multiples | 18.8x - 36.3x | 26.8x |
| Forward P/E multiples | 31.0x - 35.1x | 32.1x |
| Fair Price | (2.12) - 51.47 | 22.04 |
| Upside | -103.3% - -21.0% | -66.2% |
| Date | P/E |
| 2025-09-18 | -603.23 |
| 2025-09-17 | -577.94 |
| 2025-09-16 | -576.26 |
| 2025-09-15 | -588.06 |
| 2025-09-12 | -546.98 |
| 2025-09-11 | -559.67 |
| 2025-09-10 | -528.04 |
| 2025-09-09 | -546.36 |
| 2025-09-08 | -565.61 |
| 2025-09-05 | -574.40 |
| 2025-09-04 | -570.67 |
| 2025-09-03 | -544.59 |
| 2025-09-02 | -569.60 |
| 2025-08-29 | -601.01 |
| 2025-08-28 | -597.90 |
| 2025-08-27 | -610.19 |
| 2025-08-26 | -615.02 |
| 2025-08-25 | -639.24 |
| 2025-08-22 | -647.23 |
| 2025-08-21 | -593.56 |
| 2025-08-20 | -610.94 |
| 2025-08-19 | -622.83 |
| 2025-08-18 | -606.77 |
| 2025-08-15 | -610.94 |
| 2025-08-14 | -602.25 |
| 2025-08-13 | -614.58 |
| 2025-08-12 | -561.27 |
| 2025-08-11 | -536.60 |
| 2025-08-08 | -570.31 |
| 2025-08-07 | -563.04 |
| 2025-08-06 | -550.09 |
| 2025-08-05 | -509.55 |
| 2025-08-04 | -678.63 |
| 2025-08-01 | -664.52 |
| 2025-07-31 | -678.45 |
| 2025-07-30 | -699.03 |
| 2025-07-29 | -681.11 |
| 2025-07-28 | -685.37 |
| 2025-07-25 | -670.82 |
| 2025-07-24 | -659.38 |
| 2025-07-23 | -662.13 |
| 2025-07-22 | -633.30 |
| 2025-07-21 | -602.96 |
| 2025-07-18 | -621.41 |
| 2025-07-17 | -666.48 |
| 2025-07-16 | -701.07 |
| 2025-07-15 | -688.12 |
| 2025-07-14 | -735.00 |
| 2025-07-11 | -766.63 |
| 2025-07-10 | -801.14 |